Commercial Credit Report for Nanoform Finland Oyj

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Nanoform Finland Oyj is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Nanoform Finland Oyj
Cultivator II, Viikinkaari 4
Phone: +358 293700150p:+358 293700150	HELSINKI, 00790 Finland	Ticker: NANOFHNANOFH

Business Summary

Nanoform Finland Oyj is a Finland-based company that operates in the global pharmaceutical industry. The Company is an early-stage growth Company that develops various nanoforming technologies for application in the field of nanomedicine. Nanoform Finland Oyj’s business is to offer expert services in nanotechnology as well as drug particle engineering for global pharma and biotech industry. Nanoform Finland Oyj is the Parent Company of the Nanoform Group, and it has one subsidiary - Nanoform USA Inc. The Group production, research and development functions operate in Finland. The Group’s strategy is to sell nanotechnological services widely to minimize the dependence from single customers or projects.

(Source: F-4)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations

Officers and Directors

Title	Name	Age	Title Date	Start Date
Non-Executive Independent Chairman of the Board	Miguel M.Calado	68	1/1/2020	1/1/2019
Chief Executive Officer, Member of the Management Board	EdwardHaeggstrom	53	1/1/2015	1/1/2015
Chief Financial Officer, Member of the Management Board, Director	AlbertHaeggstrom	51	1/1/2018	1/1/2015
8 additional Officers and Directors records available in full report.

Business Names

Business Name
NANOFH
NANOFS

General Information

Number of Employees:	165	(As of 12/31/2023)
Outstanding Shares:	78,445,164	(As of 3/25/2024)
Stock Exchange:	HEL
Fax Number:	+358 88706970

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN